Novel detection assay by PCR-RFLP and frequency of the CYP3A5 SNPs, CYP3A5* 3 and * 6, in a Japanese population

Pharmacogenetics

Volumn 12, Issue 4, 2002, Pages 331-334

  Fukuen, Shuichi ^a   Fukuda, Tsuyoshi ^a   Maune, Hiromi ^a   Ikenaga, Yuka ^a   Yamamoto, Isamu ^a   Inaba, Tadanobu ^a   Azuma, Junichi ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

CYP3A5; Japanese; PCR RFLP; Single nucleotide polymorphism (SNP)

Indexed keywords

CYTOCHROME P450 3A; CYTOCHROME P450 3A5; CYP3A PROTEIN, HUMAN; CYP3A5 PROTEIN, HUMAN; CYTOCHROME P450; DNA; ENDODEOXYRIBONUCLEASE DDEI; PRIMER DNA; TYPE II SITE SPECIFIC DEOXYRIBONUCLEASE;

ALLELE; ARTICLE; ASSAY; CONTROLLED STUDY; ETHNOLOGY; GENE EXPRESSION; GENE FREQUENCY; GENE MUTATION; GENETIC SCREENING; GENETIC VARIABILITY; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MALE; NORMAL HUMAN; PHARMACOGENETICS; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RESTRICTION MAPPING; SINGLE NUCLEOTIDE POLYMORPHISM; BLOOD; CHEMISTRY; GENETICS; JAPAN; METABOLISM;

ALLELES; CYTOCHROME P-450 ENZYME SYSTEM; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; DNA; DNA PRIMERS; GENE FREQUENCY; HETEROZYGOTE; HOMOZYGOTE; HUMAN; JAPAN; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; SUPPORT, NON-U.S. GOV'T; VARIATION (GENETICS); HUMANS;

EID: 0036016319     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-200206000-00009     Document Type: Article

References (10)

1. In vitro and in vivo drug interactions involving human CYP3A
2. Genomic organization of the human CYP3A locus: Identification of a new, inducible CYP3A gene
3. cDNA cloning and initial characterization of CYP3A43, a novel human cytochrome P450
4. Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver. cDNA and deduced amino acid sequence and distinct specificities of cDNA-expressed hPCN1 and hPCN3 for the metabolism of steroid hormones and cyclosporine
5. Regioselective biotransformation of midazolam by members of the human cytochrome P450 3A (CYP3A) subfamily
6. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: Studies with liver microsomes of 30 Japanese and 30 Caucasians
7. Evaluation of the genetic component of variability in CYP3A4 activity: A repeated drug administration method
8. Ethnic differences in drug disposition and response
9. Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression
10. No ethnic difference between Caucasian and Japanese hepatic samples in the expression frequency of CYP3A5 and CYP3A7 proteins